These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 22403425)
1. A novel δ-hemolysis screening method for detecting heteroresistant vancomycin-intermediate Staphylococcus aureus and vancomycin-intermediate S. aureus. Cafiso V; Bertuccio T; Spina D; Purrello S; Blandino G; Stefani S J Clin Microbiol; 2012 May; 50(5):1742-4. PubMed ID: 22403425 [TBL] [Abstract][Full Text] [Related]
2. Screening for Intermediately Vancomycin-Susceptible and Vancomycin-Heteroresistant Staphylococcus aureus by Use of Vancomycin-Supplemented Brain Heart Infusion Agar Biplates: Defining Growth Interpretation Criteria Based on Gold Standard Confirmation. Khatib R; Riederer K; Sharma M; Shemes S; Iyer SP; Szpunar S J Clin Microbiol; 2015 Nov; 53(11):3543-6. PubMed ID: 26311860 [TBL] [Abstract][Full Text] [Related]
3. High vancomycin minimum inhibitory concentrations with heteroresistant vancomycin-intermediate Staphylococcus aureus in meticillin-resistant S. aureus bacteraemia patients. Wang JL; Lai CH; Lin HH; Chen WF; Shih YC; Hung CH Int J Antimicrob Agents; 2013 Nov; 42(5):390-4. PubMed ID: 24041465 [TBL] [Abstract][Full Text] [Related]
4. In vivo development of daptomycin resistance in vancomycin-susceptible methicillin-resistant Staphylococcus aureus severe infections previously treated with glycopeptides. Capone A; Cafiso V; Campanile F; Parisi G; Mariani B; Petrosillo N; Stefani S Eur J Clin Microbiol Infect Dis; 2016 Apr; 35(4):625-31. PubMed ID: 26815434 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA among methicillin-resistant S. aureus with high vancomycin minimal inhibitory concentrations in Taiwan: A multicenter surveillance study, 2012-2013. Huang SH; Chen YC; Chuang YC; Chiu SK; Fung CP; Lu PL; Wang LS; Wu TL; Wang JT J Microbiol Immunol Infect; 2016 Oct; 49(5):701-707. PubMed ID: 26320398 [TBL] [Abstract][Full Text] [Related]
6. Detection of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates using a combination of δ-hemolysis assay and Etest. Chang SC; Liu TP; Chen CJ; Lin LC; Lu JJ Diagn Microbiol Infect Dis; 2015 Apr; 81(4):246-50. PubMed ID: 25600843 [TBL] [Abstract][Full Text] [Related]
7. Investigation of heteroresistant vancomycin intermediate Staphylococcus aureus among MRSA isolates. Gazel D; Erinmez M; Büyüktaş Manay A; Zer Y J Infect Dev Ctries; 2021 Jan; 15(1):89-94. PubMed ID: 33571150 [TBL] [Abstract][Full Text] [Related]
8. Prevalence and accessory gene regulator (agr) analysis of vancomycin-intermediate Staphylococcus aureus among methicillin-resistant isolates in Taiwan--SMART program, 2003. Ho CM; Hsueh PR; Liu CY; Lee SY; Chiueh TS; Shyr JM; Tsao SM; Chuang YC; Yan JJ; Wang LS; Wang JH; Ho MW; Tien N; Lu JJ Eur J Clin Microbiol Infect Dis; 2010 Apr; 29(4):383-9. PubMed ID: 20155296 [TBL] [Abstract][Full Text] [Related]
9. Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia. Khatib R; Jose J; Musta A; Sharma M; Fakih MG; Johnson LB; Riederer K; Shemes S J Antimicrob Chemother; 2011 Jul; 66(7):1594-9. PubMed ID: 21525024 [TBL] [Abstract][Full Text] [Related]
10. Phenotypic characteristics and comparative proteomics of Staphylococcus aureus strains with different vancomycin-resistance levels. Sirichoat A; Lulitanond A; Kanlaya R; Tavichakorntrakool R; Chanawong A; Wongthong S; Thongboonkerd V Diagn Microbiol Infect Dis; 2016 Dec; 86(4):340-344. PubMed ID: 27717648 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Presence and Characterization of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Level Resistance Among Bloodstream Isolates of Methicillin-Resistant Ozmen Capin BB; Tekeli A; Karahan ZC Microb Drug Resist; 2020 Mar; 26(3):238-244. PubMed ID: 31545160 [No Abstract] [Full Text] [Related]
12. Ceftaroline pharmacodynamic activity versus community-associated and healthcare-associated methicillin-resistant Staphylococcus aureus, heteroresistant vancomycin-intermediate S. aureus, vancomycin-intermediate S. aureus and vancomycin-resistant S. aureus using an in vitro model. Zhanel GG; Rossnagel E; Nichol K; Cox L; Karlowsky JA; Zelenitsky S; Noreddin AM; Hoban DJ J Antimicrob Chemother; 2011 Jun; 66(6):1301-5. PubMed ID: 21429940 [TBL] [Abstract][Full Text] [Related]
13. [The incidence and risk factors for heterogeneous vancomycin intermediate Staphylococcus aureus]. Feng NN; Wang Q; Song YL; He LX; Zhou CM; Xie HM; Li HY Zhonghua Nei Ke Za Zhi; 2013 Apr; 52(4):318-22. PubMed ID: 23925360 [TBL] [Abstract][Full Text] [Related]
14. Clinical and Microbiological Characteristics of Heteroresistant and Vancomycin-Intermediate Staphylococcus aureus from Bloodstream Infections in a Brazilian Teaching Hospital. da Costa TM; Morgado PG; Cavalcante FS; Damasco AP; Nouér SA; Dos Santos KR PLoS One; 2016; 11(8):e0160506. PubMed ID: 27575698 [TBL] [Abstract][Full Text] [Related]
15. High prevalence of a globally disseminated hypervirulent clone, Staphylococcus aureus CC121, with reduced vancomycin susceptibility in community settings in China. Shen P; Zhou K; Wang Y; Song J; Liu Y; Zhou Y; Xiao Y J Antimicrob Chemother; 2019 Sep; 74(9):2537-2543. PubMed ID: 31203362 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the clinical features, bacterial genotypes and outcomes of patients with bacteraemia due to heteroresistant vancomycin-intermediate Staphylococcus aureus and vancomycin-susceptible S. aureus. Park KH; Kim ES; Kim HS; Park SJ; Bang KM; Park HJ; Park SY; Moon SM; Chong YP; Kim SH; Lee SO; Choi SH; Jeong JY; Kim MN; Woo JH; Kim YS J Antimicrob Chemother; 2012 Aug; 67(8):1843-9. PubMed ID: 22535621 [TBL] [Abstract][Full Text] [Related]
17. Protein Biomarker Discovery for Methicillin-Sensitive, Heterogeneous Vancomycin-Intermediate and Vancomycin-Intermediate Liu YC; Lu JJ; Lin LC; Lin HC; Chen CJ J Proteome Res; 2021 Jan; 20(1):164-171. PubMed ID: 33058664 [TBL] [Abstract][Full Text] [Related]
18. The Prevalence of Vancomycin-Intermediate Staphylococcus aureus and Heterogeneous VISA Among Methicillin-Resistant Strains Isolated from Pediatric Population in a Turkish University Hospital. Mirza HC; Sancak B; Gür D Microb Drug Resist; 2015 Oct; 21(5):537-44. PubMed ID: 25919019 [TBL] [Abstract][Full Text] [Related]
19. Genomic insights on heterogeneous resistance to vancomycin and teicoplanin in Methicillin-resistant Staphylococcus aureus: A first report from South India. Bakthavatchalam YD; Babu P; Munusamy E; Dwarakanathan HT; Rupali P; Zervos M; John Victor P; Veeraraghavan B PLoS One; 2019; 14(12):e0227009. PubMed ID: 31887179 [TBL] [Abstract][Full Text] [Related]
20. Detection of heterogeneous vancomycin-intermediate Amberpet R; Sistla S; Sugumar M; Nagasundaram N; Manoharan M; Parija SC Indian J Med Res; 2019 Aug; 150(2):194-198. PubMed ID: 31670275 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]